Edgewise Therapeutics (EWTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Edgewise Therapeutics (EWTX) Company Statistics | The Fly

Edgewise Therapeutics

· EWTX

Dashboard

Financials

Ratios

Valuation

Statistics

4.256 B

+3.60%

General

Market Cap: $4.26B
Enterprise Value: $4.3B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -41.11%
ROE: -39.01%
ROIC: -48.46%
Current Ratio: 16.24
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 9.75
EV/EBITDA: -21.80

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $218.31M
Operating Income: -$218.9M
Net Profit: -$197.22M

Balance Sheet

Cash and Equivalents: $72.32M
Working Capital: $442.48M
Total Assets: $479.69M
Net Debt: -$68.73M
Total Liabilities: $31.61M
Total Equity: $448.08M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$159.42M
Cash Flow from Investing: $166.4M
Cash Flow from Financing: $8.72M
Free Cash Flow: -$159.62M
Capital Expenditures: $198K